Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel
| Autor: | Eugene R. Viscusi, Sudheer Potru, Michael Sprintz, Sophia Chhay, Olabisi Lane, Anuj Aryal, Lynn Kohan, Antje M Barreveld, Anna Dopp, Trent Emerick |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Pain medicine media_common.quotation_subject Pharmacy medicine Humans Pain Management media_common business.industry Addiction Opioid use disorder General Medicine Perioperative medicine.disease Opioid-Related Disorders Acute Pain United States Buprenorphine Substance abuse Analgesics Opioid Addiction medicine Anesthesiology and Pain Medicine Family medicine business medicine.drug |
| Zdroj: | Regional anesthesia and pain medicine. 46(10) |
| ISSN: | 1532-8651 |
| Popis: | BackgroundThe past two decades have witnessed an epidemic of opioid use disorder (OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses. Medication treatment of opioid use disorder (MOUD) is effective, yet barriers to care continue to result in a large proportion of untreated individuals. Optimal analgesia can be obtained in patients with MOUD within the perioperative period. Anesthesiologists and pain physicians can recommend and consider initiating MOUD in patients with suspected OUD at the point of care; this can serve as a bridge to comprehensive treatment and ultimately save lives.MethodsThe Board of Directors of the American Society of Regional Anesthesia and Pain Medicine, American Society of Anesthesiologists, American Academy of Pain Medicine, American Society of Addiction Medicine and American Society of Health System Pharmacists approved the creation of a Multisociety Working Group on Opioid Use Disorder, representing the fields of pain medicine, addiction, and pharmacy health sciences. An extensive literature search was performed by members of the working group. Multiple study types were included and reviewed for quality. A modified Delphi process was used to assess the literature and expert opinion for each topic, with 100% consensus being achieved on the statements and each recommendation. The consensus statements were then graded by the committee members using the United States Preventive Services Task Force grading of evidence guidelines. In addition to the consensus recommendations, a narrative overview of buprenorphine, including pharmacology and legal statutes, was performed.ResultsTwo core topics were identified for the development of recommendations with >75% consensus as the goal for consensus; however, the working group achieved 100% consensus on both topics. Specific topics included (1) providing recommendations to aid physicians in the management of patients receiving buprenorphine for MOUD in the perioperative setting and (2) providing recommendations to aid physicians in the initiation of buprenorphine in patients with suspected OUD in the perioperative setting.ConclusionsTo decrease the risk of OUD recurrence, buprenorphine should not be routinely discontinued in the perioperative setting. Buprenorphine can be initiated in untreated patients with OUD and acute pain in the perioperative setting to decrease the risk of opioid recurrence and death from overdose. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|